Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1965879 | 0.97 | — | — | |
| SCHEMBL1962555 | 0.69 | CA12 (0.30) | CA1CA12CA7CA14 | |
| SCHEMBL3155782 | 0.67 | CA1 (0.41) | CA1CA12CA7CA14CES2 | |
| SCHEMBL775322 | 0.67 | CA1 (0.41) | CA1CA12CA7CA14CES2 | |
| SCHEMBL547762 | 0.67 | CA1 (0.41) | CA1CA12CA7CA14CES2 | |
| SCHEMBL24629023 | 0.67 | CA1 (0.41) | CA1CA12CA7CA14CES2 | |
| SCHEMBL11889594 | 0.67 | CA1 (0.41) | CA1CA12CA7CA14CES2 | |
| SCHEMBL329393 | 0.65 | CA1 (0.39) | CA1CA12CA7CA14CES2 | |
| SCHEMBL3003 | 0.65 | CA1 (0.39) | CA1CA12CA7CA14CES2 | |
| SCHEMBL329460 | 0.65 | CA1 (0.39) | CA1CA12CA7CA14CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110143939-A1 | QUINOXALIN-2-ONE DERIVATIVES, COMPOSITIONS WHICH PROTECT USEFUL PLANTS AND COMPRISE THESE DERIVATIVES, AND PROCESSES FOR THEIR PREPARATION AND THEIR USE | BAYER CROPSCIENCE AG (DE) | 2011-06-16 | — | — | US | disclosed |
| US-7332509-B2 | Heterocyclic amides, a process for their preparation, compositions comprising them and their use | MERIAL LIMITED (US) | 2008-02-19 | — | — | US | disclosed |
| US-20060173022-A1 | Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides | BAYER CROPSCIENCE GMBH (DE) | 2006-08-03 | — | — | US | disclosed |
| US-20050256000-A1 | Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use | BAYER CROPSCIENCE GMBH (DE) | 2005-11-17 | — | — | US | disclosed |
| US-20040006047-A1 | Heterocyclic amides, a process for their preparation, compositions comprising them and their use | MERIAL LIMITED | 2004-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256000-A1 | Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use | QSOX1, CYC1, CBR3 | CA1 1753/4885CA12 3309/4885CA7 1415/4885 |
| US-20110143939-A1 | QUINOXALIN-2-ONE DERIVATIVES, COMPOSITIONS WHICH PROTECT USEFUL PLANTS AND COMPRISE THESE DERIVATIVES, AND PROCESSES FOR THEIR PREPARATION AND THEIR USE | QSOX1, PRDX2, NQO2 | CA1 1868/4885CA12 4121/4885CA7 2233/4885 |
| US-20040006047-A1 | Heterocyclic amides, a process for their preparation, compositions comprising them and their use | CBR1, HCN1, SCN1A | CA1 117/4885CA12 753/4885CA7 355/4885 |
| US-20060173022-A1 | Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides | CBR3, CBR1, C3AR1 | CA1 807/4885CA12 1443/4885CA7 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.